COVID-19 - International Biopharmaceutical Industry

news

FDA places stricter limits on J&J’s COVID-19 vaccine after review of rare side effect

Dive Brief: The Food and Drug Administration has determined that the risk of a rare, but serious, clotting syndrome tied to Johnson & Johnson’s COVID-19 vaccin...

9 May 2022 news COVID-19 | FDA

Continue Reading →

news

FDA sets back Novartis’ best chance at a COVID-19 drug

Dive Brief: Novartis is reevaluating its commitment to an experimental COVID-19 treatment originally developed by fellow Swiss drug company Molecular Partners afte...

28 April 2022 news Amgen | COVID-19

Continue Reading →

news

Drug price hikes moderate as rebates rise, report finds

Dive Brief: List prices of branded drugs in the U.S. rose by an average of nearly 5% last year, according to a report released Thursday by Iqvia, a consultancy and...

25 April 2022 news COVID-19 | Drug

Continue Reading →

news

FDA advisers grapple with how to update COVID-19 vaccines

A group of advisers to the Food and Drug Administration agreed Wednesday that COVID-19 vaccines will likely need to be updated to keep pace with a fast-changing coron...

11 April 2022 news COVID-19 | dose

Continue Reading →

news

Moderna, with new data, to seek clearance for COVID-19 vaccine in young children

Moderna on Wednesday said its COVID-19 vaccine spurred strong immune responses in a large study testing the shot in children as young as 6 months old, results that th...

25 March 2022 news children | COVID-19

Continue Reading →

news

Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Dive Brief: Moderna has asked the Food and Drug Administration to clear a fourth dose of its COVID-19 vaccine for adults 18 and over, a broader request than Pfizer...

21 March 2022 news adults | BioNTech

Continue Reading →

news

Amid biotech downturn, Atlas raises $450M to build new drug startups

Dive Brief: Atlas Venture, a prolific creator of biotech startups, has raised $450 million to form and invest in new drug companies, announcing Thursday the closin...

4 March 2022 news Atlas | Biotech

Continue Reading →

news

Sanofi and GSK, after delays, to seek clearance for COVID-19 vaccine

Sanofi and GlaxoSmithKline plan to seek authorization for their experimental coronavirus vaccine in the U.S. and abroad after their shot prevented COVID-19 in a large...

24 February 2022 news coronavirus | COVID-19

Continue Reading →

news

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Dive Brief: Pfizer on Tuesday forecast that its revenue this year will grow to total between $98 billion and $102 billion, which, measured at the range's midpoint,...

10 February 2022 news COVID-19 | Pfizer

Continue Reading →

news

Pfizer lures research chief from Roche, prompting high-level reshuffle

Dive Brief: Pfizer is hiring William Pao, currently Roche's head of pharmaceutical research and early development, to serve as its chief development officer and ex...

6 February 2022 news Comirnaty | COVID-19

Continue Reading →

Current Edition

Upcoming Events

Advertisement

FDA places stricter limits on J&J’s COVID-19 vaccine after review of rare side effect

FDA sets back Novartis’ best chance at a COVID-19 drug

Drug price hikes moderate as rebates rise, report finds

FDA advisers grapple with how to update COVID-19 vaccines

Moderna, with new data, to seek clearance for COVID-19 vaccine in young children

Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Amid biotech downturn, Atlas raises $450M to build new drug startups

Sanofi and GSK, after delays, to seek clearance for COVID-19 vaccine

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Pfizer lures research chief from Roche, prompting high-level reshuffle

International Biopharmaceutical Industry